DSP Mutual Fund trimmed its stake in Aarti Drugs Limited from 8.01% to 7.93%, selling 70,308 shares.
A pharmaceutical manufacturer established in 1984, Aarti Drugs produces Active Pharmaceutical Ingredients, pharma intermediates, specialty chemicals, and formulations for domestic and international markets. Part of the larger Aarti Group of Industries, the company operates as a vertically integrated manufacturer serving pharmaceutical clients globally. Its diverse product portfolio spans APIs, chemical intermediates, and finished pharmaceutical formulations across multiple therapeutic segments and industrial applications.
Standalone AMC after DSP Group acquired full ownership from BlackRock in 2018. Manages over Rs 1.9 lakh crore. Known for equity funds with a clear process-first culture and minimal star manager dependency. CEO Kalpen Parekh is widely respected for transparent investor communication. DSP Small Cap Fund and DSP Midcap Fund are flagship offerings.
